All coronavirus articles – Page 3
-
BusinessWhy manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
NewsPractical chemistry classes resume at English universities
Lifting of lockdown restrictions allows students to return to teaching laboratories
-
BusinessCoronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
OpinionA rough guide to pharma partnership deals
Coronavirus vaccines are driving unusual collaborations with a range of benefits
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
OpinionObserving the state’s transition
Sweeping changes on both sides of the Atlantic have yet to deliver on their promises
-
OpinionBusiness as usual?
The pandemic has shown that we can react quickly to complex problems – can we do it to avert a climate crisis?
-
NewsDecoding the virus – what we know about Sars-CoV-2 a year on
Scientists have never learnt so much about a pathogen in such a short time
-
BusinessCan chemistry thaw the vaccine cold chain?
Covid-19 has highlighted the challenges of storing vaccines at their proper temperature. Angeli Mehta explores how scientists are trying to protect vaccines from heat degradation
-
OpinionBert Meijer: ‘I'm in love with molecules’
The pioneering organic chemist discusses the rewards of working with young people and the role of chemistry in fighting Covid-19
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
OpinionChemists amid coronavirus: 2020 in review
How the pandemic has changed the way we live and work around the world
-
CareersUnderrepresented scientists hardest hit by pandemic
The effects of Covid-19 have exacerbated existing inequalities in academia
-
BusinessCybercriminals target Covid-19 vaccines
Officials in the UK and US warn of threat from cyber-attacks that steal data related to Covid-19 vaccines and aim to disrupt the supply chain
-
Feature2020: the year the world changed
Andy Extance discovers how scientists around the world have responded to the pandemic, working on solutions from drugs and vaccines to hand sanitiser and PPE
-
BusinessPfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
OpinionStirring in my sleep
Cut off from the lab after 40 years, Derek Lowe returns to the bench in his dreams
-
ResearchAnimal tests reveal synthetic decoy protein protects against coronavirus
Protein designed from scratch binds Sars-CoV-2 with high affinity and specificity
-
BusinessUK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data